How Our Partners at AWS Keep Drug Development Data Safe in the Cloud
Questions about security and compliance continue to hold many drug developers back from adopting cloud-based solutions. Our CTO Ryan Shillington sat down with AWS solution architect Reef D’Souza to talk about some of their most common concerns.
Compliance Architects® Identifies QbDVision as Best-In-Class Platform to Drive Structural Compliance in Drug Development
We are thrilled to announce that we are partnering with Compliance Architects (CA) to combine the power of our QbDVision Digital CMC™ software platform with CA’s deep experience in quality and regulatory compliance. Together, we plan to accelerate the development of robust manufacturing processes for pharma and biotech products.